Top

Acta Neurochirurgica

Published in:

Open Access 04-10-2023 | Statins | Original Article

The impact of pre-ictal statin use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage

Authors: S. Andersen, E. Western, W. Sorteberg, A. Sorteberg

Published in: Acta Neurochirurgica | Issue 11/2023

Abstract

Background

Pleiotropic effects of statins may be beneficial in alleviating cerebral vasospasm (VS) and improving outcome after aneurysmal subarachnoid hemorrhage (aSAH). Initiation of statin treatment at aSAH is not recommended; however, the effect of pre-ictal and continued statin use is not fully investigated.

Methods

Retrospective study comparing aSAH patients admitted in 2012 to 2021 with pre-ictal statin use versus those not using statins. Patient entry variables, radiological/sonological VS, symptomatic VS, and radiologically documented delayed cerebral ischemia (DCI) were registered. Outcome was scored in terms of mortality, modified Rankin score, Glasgow outcome score extended, and levels of fatigue. Patients were compared on group level and in a case–control design.

Results

We included 961 patients, with 204 (21.2%) statin users. Statin users were older and had more often hypertension. Severe radiological/sonological VS, symptomatic VS, and DCI were less frequent in statin users, and their length of stay was shorter. Mortality, functional outcome, and levels of fatigue were similar in both groups. When analyzing 89 pairs of statin users and non-statin users matched for age, aSAH severity, gender, and hypertension, we confirmed decreased radiological/sonological and symptomatic VS as well as shorter length of stay in statin users. They also had more often a favorable functional outcome and lower levels of fatigue.

Conclusions

Patients with pre-ictal and continued use of statins have a reduced occurrence of radiological/sonological and symptomatic VS, shorter length of stay, and more often favorable functional outcome, whereas mortality is similar to non-statin users. Even though larger multicenter studies with common, strict protocols for prevention, diagnosis, and treatment of vasospasm are needed to finally establish the value of statins in aSAH, continuation of pre-ictal statin use seems worthwhile.

Ayer RE, Zhang JH (2008) Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 104:33–41. https://doi.org/10.1007/978-3-211-75718-5_7CrossRefPubMedPubMedCentral

Baggott CD, Aagaard-Kienitz B (2014) Cerebral vasospasm. Neurosurg Clin N Am 25:497–528. https://doi.org/10.1016/j.nec.2014.04.008CrossRefPubMed

Bonita R, Beaglehole R (1988) Recovery of motor function after stroke. Stroke 19:1497–1500. https://doi.org/10.1161/01.STR.19.12.1497CrossRefPubMed

Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 101:364–370. https://doi.org/10.1016/S0002-9343(96)00234-3CrossRefPubMed

Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD (2013) Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol 9:152–163. https://doi.org/10.1038/nrneurol.2013.11CrossRefPubMed

Chou SH-Y, Smith EE, Badjatia N, Nogueira RG, Sims JR, Ogilvy CS, Rordorf GA, Ayata C (2008) A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39:2891–2893. https://doi.org/10.1161/STROKEAHA.107.505875CrossRefPubMed

Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ (2009) Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology 51:813–819. https://doi.org/10.1007/s00234-009-0575-yCrossRefPubMedPubMedCentral

Diringer MN, Dhar R, Scalfani M, Zazulia AR, Chicoine M, Powers WJ, Derdeyn CP (2016) Effect of high-dose simvastatin on cerebral blood flow and static autoregulation in subarachnoid hemorrhage. Neurocrit Care 25:56–63. https://doi.org/10.1007/s12028-015-0233-7CrossRefPubMedPubMedCentral

Dorsch NWC (1995) Cerebral arterial spasm-a clinical review. Br J Neurosurg 9:403–412. https://doi.org/10.1080/02688699550041403CrossRefPubMed

10.

Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl U, Bohner G, Strong AJ, group ftCs (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132:1866–1881. https://doi.org/10.1093/brain/awp102CrossRefPubMedPubMedCentral

11.

Faßbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schütt S, Fritzinger M, Horn P, Vajkoczy P, Wendel-Wellner M, Ragoschke A, Kuehl S, Brunner J, Schürer L, Schmiedeck P, Hennerici M (2000) Endothelin-1 in subarachnoid hemorrhage. Stroke 31:2971–2975. https://doi.org/10.1161/01.STR.31.12.2971CrossRefPubMed

12.

Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876–883. https://doi.org/10.1212/wnl.50.4.876CrossRefPubMed

13.

Felger JC (2017) The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Curr Top Behav Neurosci 31:199–219. https://doi.org/10.1007/7854_2016_13CrossRefPubMed

14.

Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9. https://doi.org/10.1227/00006123-198001000-00001CrossRefPubMed

15.

Francoeur CL, Mayer SA (2016) Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 20:277. https://doi.org/10.1186/s13054-016-1447-6CrossRefPubMedPubMedCentral

16.

Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, Macdonald RL, Mayer SA (2006) Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery 59:21–27. https://doi.org/10.1227/01.neu.0000243277.86222.6cCrossRefPubMed

17.

Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, Connolly ES, Mayer SA (2009) Defining vasospasm after subarachnoid hemorrhage. Stroke 40:1963–1968. https://doi.org/10.1161/STROKEAHA.108.544700CrossRefPubMed

18.

Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432–446. https://doi.org/10.1007/s12975-013-0257-2CrossRefPubMedPubMedCentral

19.

Garg K, Sinha S, Kale SS, Chandra PS, Suri A, Singh MM, Kumar R, Sharma MS, Pandey RM, Sharma BS, Mahapatra AK (2013) Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled pilot trial. Br J Neurosurg 27:181–186. https://doi.org/10.3109/02688697.2012.757293CrossRefPubMed

20.

Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, Sahebkar A (2019) Statin-induced nitric oxide signaling: mechanisms and therapeutic implications. J Clin Med 8. https://doi.org/10.3390/jcm8122051

21.

Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28:252–256. https://doi.org/10.1016/j.tips.2007.04.002CrossRefPubMed

22.

Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, Hänggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, Welch BG (2023) 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 54 (7): e314-e370, originally published May 22, 2023. https://doi.org/10.1161/STR.0000000000000436

23.

Ivanidze J, Kesavabhotla K, Kallas ON, Mir D, Baradaran H, Gupta A, Segal AZ, Claassen J, Sanelli PC (2015) Evaluating blood-brain barrier permeability in delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 36:850–854. https://doi.org/10.3174/ajnr.A4207CrossRefPubMedPubMedCentral

24.

Karshikoff B, Sundelin T, Lasselin J (2017) Role of inflammation in human fatigue: relevance of multidimensional assessments and potential neuronal mechanisms. Front Immunol 8:21. https://doi.org/10.3389/fimmu.2017.00021CrossRefPubMedPubMedCentral

25.

Khanafer A, Bhogal P, Hellstern V, Harmening C, Bäzner H, Ganslandt O, Henkes H (2022) Vasospasm-related death after aneurysmal subarachnoid hemorrhage: a retrospective case-control study. J Clin Med 11. https://doi.org/10.3390/jcm11164642

26.

Kimball MM, Velat GJ, Hoh BL (2011). The participants in the International Multi-disciplinary Consensus Conference on the critical care management of subarachnoid hemorrhage. Critical Care Guidelines on the Endovascular Management of Cerebral Vasospasm. Neurocrit Care 15(2):336–41. https://doi.org/10.1007/s12028-011-9600-1

27.

Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD (2014) Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol 13:666–675. https://doi.org/10.1016/s1474-4422(14)70084-5CrossRefPubMed

28.

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123. https://doi.org/10.1001/archneur.1989.00520460115022CrossRefPubMed

29.

Kutlubaev MA, Barugh AJ, Mead GE (2012) Fatigue after subarachnoid haemorrhage: a systematic review. J Psychosom Res 72:305–310. https://doi.org/10.1016/j.jpsychores.2011.12.008CrossRefPubMed

30.

Lanzino G, Kassell NF, Germanson TP, Kongable GL, Truskowski LL, Torner JC, Jane JA (1996) Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg 85:410–418. https://doi.org/10.3171/jns.1996.85.3.0410CrossRefPubMed

31.

Laufs U (2003) Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 58:719–731. https://doi.org/10.1007/s00228-002-0556-0CrossRefPubMed

32.

Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135. https://doi.org/10.1161/01.cir.97.12.1129CrossRefPubMed

33.

LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR (1992) Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 31:678–684; discussion 684–675. https://doi.org/10.1227/00006123-199210000-00010

34.

Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P (1989) Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 100:12–24. https://doi.org/10.1007/bf01405268CrossRefPubMed

35.

Lippi G, Mattiuzzi C, Cervellin G (2019) Statins popularity: a global picture. Br J Clin Pharmacol 85:1614–1615. https://doi.org/10.1111/bcp.13944CrossRefPubMedPubMedCentral

36.

Lizza BD, Kosteva A, Maas MB, Rosenberg NF, Liotta E, Guth J, Levasseur-Franklin KE, Naidech AM (2014) Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage. Pharmacotherapy: J Human Pharmacol Drug Ther 34:811–817. https://doi.org/10.1002/phar.1436CrossRef

37.

Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT (2005) Simvastatin Reduces vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 36:2024–2026. https://doi.org/10.1161/01.STR.0000177879.11607.10CrossRefPubMed

38.

Macedo S, Bello Y, Silva A, Siqueira C, Siqueira S, Brito L (2009) Effects of simvastatin in prevention of vasospasm in nontraumatic subarachnoid hemorrhage: preliminary data. Crit Care 13:P103–P103. https://doi.org/10.1186/cc7267CrossRefPubMedCentral

39.

Miller BA, Turan N, Chau M, Pradilla G (2014) Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int 2014:384342. https://doi.org/10.1155/2014/384342CrossRefPubMedPubMedCentral

40.

Moskowitz SI, Ahrens C, Provencio JJ, Chow M, Rasmussen PA (2009) Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 71:311–317, discussion 317–318. https://doi.org/10.1016/j.surneu.2007.12.027

41.

Naraoka M, Matsuda N, Shimamura N, Asano K, Akasaka K, Takemura A, Hasegawa S, Ohkuma H (2018) Long-acting statin for aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. J Cereb Blood Flow Metab 38:1190–1198. https://doi.org/10.1177/0271678x17724682CrossRefPubMed

42.

Ohkuma H, Manabe H, Tanaka M, Suzuki S (2000) Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31:1621–1627. https://doi.org/10.1161/01.STR.31.7.1621CrossRefPubMed

43.

Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons B-FM, Janjua N, Mayer SA, Connolly ESJ (2005) Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56:476–484. https://doi.org/10.1227/01.Neu.0000153925.96889.8aCrossRefPubMed

44.

Pradilla G, Chaichana KL, Hoang S, Huang J, Tamargo RJ (2010) Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am 21:365–379. https://doi.org/10.1016/j.nec.2009.10.008CrossRefPubMed

45.

Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale (1988). J Neurosurg 68(6):985–986. https://doi.org/10.3171/jns.1988.68.6.0985

46.

Rivero Rodríguez D, Scherle Matamoros C, Fernández Cúe L, Miranda Hernández JL, Pernas Sánchez Y, Pérez Nellar J (2017) Factors associated with poor outcome for aneurysmal subarachnoid haemorrhage in a series of 334 patients. Neurologia 32:15–21. https://doi.org/10.1016/j.nrl.2014.12.006CrossRefPubMed

47.

Ryttlefors M, Enblad P, Ronne-Engström E, Persson L, Ilodigwe D, Macdonald RL (2010) Patient age and vasospasm after subarachnoid hemorrhage. Neurosurgery 67:911–917. https://doi.org/10.1227/NEU.0b013e3181ed11abCrossRefPubMed

48.

Shen J, Huang KY, Zhu Y, Pan JW, Jiang H, Weng YX, Zhan RY (2017) Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg 127:291–301. https://doi.org/10.3171/2016.5.Jns152900CrossRefPubMed

49.

Shen J, Shen J, Zhu K, Zhou H, Tian H, Yu G (2019) Efficacy of statins in cerebral vasospasm, mortality, and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials. World Neurosurg 131:e65–e73. https://doi.org/10.1016/j.wneu.2019.07.016CrossRefPubMed

50.

Sillberg VAH, Wells GA, Perry JJ (2008) Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 39:2622–2626. https://doi.org/10.1161/STROKEAHA.107.508341CrossRefPubMed

51.

Sorteberg W, Slettebø H, Eide PK, Stubhaug A, Sorteberg A (2008) Surgical treatment of aneurysmal subarachnoid haemorrhage in the presence of 24-h endovascular availability: management and results. Br J Neurosurg 22:53–62. https://doi.org/10.1080/02688690701593553CrossRefPubMed

52.

To MS, Prakash S, Poonnoose SI, Bihari S (2018) Dose-dependent effects of statins for patients with aneurysmal subarachnoid hemorrhage: meta-regression analysis. World Neurosurg 113:153–162. https://doi.org/10.1016/j.wneu.2018.01.184CrossRefPubMed

53.

Tseng M-Y, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. Stroke 36:1627–1632. https://doi.org/10.1161/01.STR.0000176743.67564.5dCrossRefPubMed

54.

van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL (2009) Statins: mechanisms of neuroprotection. Prog Neurobiol 88:64–75. https://doi.org/10.1016/j.pneurobio.2009.02.002CrossRefPubMed

55.

Vaughan CJ, Delanty N (1999) Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30:1969–1973. https://doi.org/10.1161/01.STR.30.9.1969CrossRefPubMed

56.

Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB (2009) Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 29:1444–1453. https://doi.org/10.1038/jcbfm.2009.59CrossRefPubMed

57.

Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761–1770. https://doi.org/10.1038/jcbfm.2008.74CrossRefPubMed

58.

Western E, Sorteberg A, Brunborg C, Nordenmark TH (2020) Prevalence and predictors of fatigue after aneurysmal subarachnoid hemorrhage. Acta Neurochir 162:3107–3116. https://doi.org/10.1007/s00701-020-04538-9CrossRefPubMed

59.

Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma 15:573–585. https://doi.org/10.1089/neu.1998.15.573CrossRefPubMed

60.

Yin L, Ma CY, Li ZK, Wang DD, Bai CM (2011) Predictors analysis of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 110(Pt 2):175–8. https://doi.org/10.1007/978-3-7091-0356-2_3261CrossRefPubMed

61.

Zhou C, Yamaguchi M, Colohan AR, Zhang JH (2005) Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 25:572–582. https://doi.org/10.1038/sj.jcbfm.9600069CrossRefPubMed

Title: The impact of pre-ictal statin use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage
Authors: S. Andersen
E. Western
W. Sorteberg
A. Sorteberg
Publication date: 04-10-2023
Publisher: Springer Vienna
Keywords: Statins
Fatigue
Subarachnoid Hemorrhage
Subarachnoid Hemorrhage
Nimodipine
Published in: Acta Neurochirurgica / Issue 11/2023
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-023-05812-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The impact of pre-ictal statin use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2023

Poor patient-reported mental health correlates with inferior patient-reported outcome measures following cervical disc replacement

Implementation of the Enhanced Recovery After Surgery (ERAS®) program in neurosurgery

Early surgery versus conservative treatment in patients with traumatic intracerebral hematoma: a CENTER-TBI study

The “candy wrapper” of the pituitary gland: a road map to the parasellar ligaments and the medial wall of the cavernous sinus

How I do it: simplified craniotomy for acute subdural hematoma in the elderly

Effect of baseline veterans RAND-12 physical composite score on postoperative patient-reported outcome measures following lateral lumbar interbody fusion